About VetBiotek
VetBiotek is a Healthcare company based in Largo (United States) founded in 2014, and was acquired by Nextmune in December 2023. Veterinary solutions are provided for managing health conditions in animals. Its chief executive, as recorded, is Thomas Bell. VetBiotek offers products and services including Dermatology Products and Joint Support Products. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Diversified. Its legal entity is VetBiotek, Inc. Its competitors include KindredBio and Bactana Corporation; 2 of its 2 listed competitors have raised funding.
Company details
VetBiotek was founded in 2014 in Largo, United States, operating in the veterinary medicine sector. Products including MicroSilver BG, Ceramide III, AyuFlex, BiovaPlex, UC-II, and VitaBerry are supplied to address dermatology cases, liver disease, and joint support. These offerings assist veterinarians in handling common animal health issues through targeted formulations.
- Headquarters Largo, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vetbiotek.com
- Social LinkedIn
- Acquired by Nextmune (Dec 2023)
- Legal Name Vetbiotek, Inc.
Products & Services of VetBiotek
VetBiotek offers a comprehensive portfolio of products and services, including Dermatology Products and Joint Support Products.
Products for treating animal skin conditions effectively.
Supplements to enhance animal joint health and mobility.
Investors in VetBiotek
VetBiotek has secured backing from 1 investor. Prominent investors backing the company include Nextmune.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global company offering pet health products in allergy, dermatology, and nutrition services. | 2016 | nextmune.com | Stockholm, Sweden |
Investor details for VetBiotek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VetBiotek
1 people are tracked at VetBiotek (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Bell | CEO | Leadership |
Complete people profiles for VetBiotek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VetBiotek
2 dated milestones of VetBiotek across 9 years, from founding to its latest funding, stage changes and deals.
- Founded VetBiotek is founded.
- Exit Acquired by Nextmune.
Competitors of VetBiotek
VetBiotek has 2 listed competitors in our database, 2 of them funded. They include KindredBio and Bactana Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kindredbio.com | 2012 | Burlingame, United States | $6.9M | 64 | Veterinary antibodies for cats, dogs, and horses are developed. | |
| bactana.com | 2016 | Farmington, United States | $1.76M | Proprietary microbiome technology is developed for companion and food animals. |
Detailed competitors of VetBiotek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Veterinary Digital Health
3 companies that operate in the same segment as VetBiotek (Veterinary Digital Health) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | |||
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | |||
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VetBiotek
VetBiotek was founded in 2014.
VetBiotek is headquartered in Largo, United States. It is registered at Largo, Florida, United States.
Thomas Bell is the CEO of VetBiotek, as recorded in our data.
VetBiotek was founded in 2014 in Largo, United States, operating in the veterinary medicine sector. Products including MicroSilver BG, Ceramide III, AyuFlex, BiovaPlex, UC-II, and VitaBerry are supplied to address dermatology cases, liver disease, and joint support. These offerings assist veterinarians in handling common animal health issues through targeted formulations.
VetBiotek's top competitors include KindredBio and Bactana Corporation.
VetBiotek offers Dermatology Products and Joint Support Products.
VetBiotek has 1 investor. Key investors include Nextmune.
VetBiotek operates through Vetbiotek, Inc..
Yes. VetBiotek was acquired by Nextmune in December 2023.